Martin Shkreli, the former CEO of Retrophin and Turing Pharmaceuticals, who was made famous by a 5,000 percent price hike on a cancer and AIDS drug, now faces an additional conspiracy charge, according to The Wall Street Journal.
Both Mr. Shkreli and his former lawyer, Evan Greebel, were charged Friday by federal prosecutors for securities fraud conspiracy, according to the report. The charges are related to Mr. Shkreli's control over shares of Retrophin, and his failure to disclose this information to the Securities and Exchange Commission, according to the report.
Both Mr. Shkreli and his lawyer now face eight total counts of fraud and conspiracy to commit fraud, according to a CNN Money report. Mr. Shkreli pleaded not guilty in a Brooklyn court Monday, according to the report. He is not worried about this additional charge, though he said he is preparing to learn mixed martial arts in the event he goes to prison, according to CNN Money.
More articles on legal and regulatory issues:
14 latest healthcare industry lawsuits, settlements
Lee Memorial wants to evict another patient
Mississippi health system to pay $150M over failed pension plan